EVEREST2016-12-12T20:25:39+00:00

EVEREST

EVEREST image from New Medical Terms

EVEREST

CARDIOLOGY

Definition A trial that asked whether tolvaptan, a vasopressin V2 receptor blocker, improved outcomes of patients hospitalised with heart failure.

Logistics Multicentre, multinational event-driven, randomised, double-blind, placebo-controlled study involving 4133 patients.

Conclusion No it doesn’t.

Abbreviation for Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan 

Reference J Am Coll Cardio 2008; 52:1640 

http://www.ncbi.nlm.nih.gov/pubmed/18992654?dopt=Abstract

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.